HomepageDASA3 • BVMF
add
Diagnosticos da America SA
Vorige slotkoers
R$Â 4,35
Dag-range
R$Â 4,38 - R$Â 4,73
Jaar-range
R$Â 1,18 - R$Â 4,73
Beurswaarde
5,70Â mld. BRL
Gem. volume
3,36Â mln.
Koers/winst
-
Dividendrendement
-
Primaire beurs
BVMF
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (BRL) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 2,61Â mld. | -34,28% |
Bedrijfskosten | 499,58Â mln. | -28,69% |
Netto inkomsten | 95,81Â mln. | 209,51% |
Netto winstmarge | 3,67 | 266,82% |
Winst per aandeel | — | — |
EBITDA | 499,10Â mln. | -14,03% |
Effectief belastingtarief | -28,29% | — |
Balans
Totale activa
Totale passiva
| (BRL) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 2,55Â mld. | -8,56% |
Totale activa | 21,10Â mld. | -25,42% |
Totale passiva | 13,26Â mld. | -32,56% |
Totaal aandelenvermogen | 7,84 mld. | — |
Uitstaande aandelen | 1,25 mld. | — |
Koers-boekwaardeverhouding | 0,69 | — |
Rendement op activa | 4,62% | — |
Rendement op kapitaal | 5,43% | — |
Kasstroom
Nettomutatie in liquide middelen
| (BRL) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 95,81Â mln. | 209,51% |
Operationele kasstroom | 434,13Â mln. | 91,54% |
Kasstroom uit beleggingen | 570,01Â mln. | 834,61% |
Kasstroom uit financiering | 196,58Â mln. | 160,69% |
Nettomutatie in liquide middelen | 1,20Â mld. | 786,67% |
Vrije kasstroom | 192,31Â mln. | 164,55% |
Over
Diagnósticos da América S.A. is a Brazil-based clinical diagnostics company. It also operates a food testing unit, advertising, publishing, human resources services, and research entities.
Founded in 1961, the company originally known as Laboratório ClÃnico Delboni Auriemo is headquartered in Barueri, Greater São Paulo and it is owned by the Brazilian billionaire family Bueno.
Currently, it competes in Brazil with Amil, Fleury and Rede D'Or and its clinics work with numerous brands, such as Alvaro, CientÃficaLab, Lavoisier, Delboni Auriemo, Alta, Leforte and Christóvão da Gama.
In 2024, Dasa and Amil agreed to combine their hospital operations in a 50/50 joint venture, comprising 25 hospitals and several oncology clinics. Wikipedia
Opgericht
1961
Website
Werknemers
18.142
